The therapy tweaks the cancer patient's own immune cells to recognize and attack cancer cells.
In a study involving five adults with acute lymphoblastic leukemia, researchers found the therapy shrunk tumors and sent the cancer into remission.
The study is published in the journal Science Translational Medicine.